- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1369
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1369 companies
H. Lundbeck
Market Cap: DKK 43.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 45.42
7D
1.4%
1Y
2.7%
Beijing Tongrentang
Market Cap: CN¥46.8b
Engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally.
600085
CN¥34.15
7D
-2.4%
1Y
-4.9%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥46.5b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥27.97
7D
-4.3%
1Y
-10.7%
Rhythm Pharmaceuticals
Market Cap: US$6.4b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$99.14
7D
0.6%
1Y
93.9%
PharmaEssentia
Market Cap: NT$191.9b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$519.00
7D
6.8%
1Y
-9.3%
Shanghai RAAS Blood Products
Market Cap: CN¥44.2b
Engages in the manufacture and sale of blood products in China.
002252
CN¥6.69
7D
-1.8%
1Y
-6.4%
Legend Biotech
Market Cap: US$6.1b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$32.82
7D
-6.7%
1Y
-29.9%
Axsome Therapeutics
Market Cap: US$5.9b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$116.01
7D
-2.2%
1Y
29.4%
SK Biopharmaceuticals
Market Cap: ₩8.2t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩105,200.00
7D
-2.5%
1Y
-2.5%
Nuvalent
Market Cap: US$5.7b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$77.52
7D
-4.2%
1Y
-23.3%
Shanghai Junshi Biosciences
Market Cap: HK$43.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$30.92
7D
-5.6%
1Y
153.0%
Asymchem Laboratories (Tianjin)
Market Cap: CN¥39.6b
Asymchem Laboratories (Tianjin) Co., Ltd.
002821
CN¥111.72
7D
-2.2%
1Y
61.0%
CRISPR Therapeutics
Market Cap: US$5.6b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
CRSP
US$60.32
7D
-4.2%
1Y
29.7%
Bachem Holding
Market Cap: CHF 4.4b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 58.15
7D
-10.7%
1Y
-18.2%
Ono Pharmaceutical
Market Cap: JP¥801.7b
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥1,706.50
7D
-0.8%
1Y
-13.9%
Biocon
Market Cap: ₹473.7b
Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.
BIOCON
₹355.95
7D
-3.4%
1Y
-4.5%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Market Cap: Ft1.8t
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
RICHTER
Ft9,775.00
7D
-1.0%
1Y
-12.2%
Beijing Tiantan Biological Products
Market Cap: CN¥37.6b
Beijing Tiantan Biological Products Co., Ltd.
600161
CN¥19.00
7D
-3.0%
1Y
-16.1%
Shanghai Henlius Biotech
Market Cap: HK$40.3b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$74.15
7D
-9.8%
1Y
223.1%
TG Therapeutics
Market Cap: US$5.2b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$34.64
7D
6.2%
1Y
48.5%
Merus
Market Cap: US$5.2b
A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.
MRUS
US$68.10
7D
-1.2%
1Y
44.3%
Zealand Pharma
Market Cap: DKK 31.7b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 449.90
7D
-3.4%
1Y
-45.8%
Humanwell Healthcare (Group)Ltd
Market Cap: CN¥34.8b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
600079
CN¥21.29
7D
-2.5%
1Y
14.8%
Bruker
Market Cap: US$4.9b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$30.78
7D
-7.5%
1Y
-56.3%
Chengdu Kanghong Pharmaceutical Group
Market Cap: CN¥34.0b
Research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China.
002773
CN¥36.95
7D
-6.2%
1Y
101.4%
Xiamen Amoytop Biotech
Market Cap: CN¥34.0b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥83.66
7D
5.2%
1Y
38.3%
PTC Therapeutics
Market Cap: US$4.7b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTCT
US$57.84
7D
-8.0%
1Y
53.6%
Hikma Pharmaceuticals
Market Cap: UK£3.5b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£15.92
7D
-2.7%
1Y
-15.2%
Krystal Biotech
Market Cap: US$4.7b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$161.15
7D
0.3%
1Y
-9.7%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥33.0b
Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.
688192
CN¥71.89
7D
1.2%
1Y
102.6%
Alkermes
Market Cap: US$4.6b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$27.13
7D
-5.0%
1Y
-0.1%
Livzon Pharmaceutical Group
Market Cap: CN¥32.2b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
000513
CN¥38.66
7D
-2.3%
1Y
4.3%
InnoCare Pharma
Market Cap: HK$34.9b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$17.70
7D
5.0%
1Y
216.6%
China Medical System Holdings
Market Cap: HK$34.9b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.44
7D
-3.9%
1Y
77.6%
Genscript Biotech
Market Cap: HK$34.7b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$15.88
7D
-7.9%
1Y
40.5%
Sotera Health
Market Cap: US$4.5b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$15.54
7D
-2.7%
1Y
-6.3%